Biotech · Private company
Bexion Pharmaceuticals, Inc.
Track this companyFree. Adds Bexion Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BXQ-350Phase 2 · Metastatic Colorectal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BXQ-350Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- BXQ-350Phase 1 · Neuropathy;PeripheralClinicalTrials.gov · fetched Nov 12, 2026
- BXQ-350 - Part 1 Dose Escalation: Safety and TolerancePhase 1 · Diffuse Intrinsic Pontine GliomaClinicalTrials.gov · fetched Nov 12, 2026
- BXQ-350 - Part 2 BXQ-350 Tumor and Plasma ConcentrationsPhase 1 · Diffuse Intrinsic Pontine GliomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- BXQ-350 in Newly Diagnosed Metastatic Colorectal CarcinomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 9, 2023ClinicalTrials.gov NCT05322590 · fetched Nov 12, 2026
- BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer PatientsEARLY_PHASE1 · COMPLETED · started Oct 17, 2022ClinicalTrials.gov NCT05291286 · fetched Nov 12, 2026
- A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)PHASE1 · TERMINATED · started May 24, 2021ClinicalTrials.gov NCT04771897 · fetched Nov 12, 2026
- Continued Treatment for Participants Enrolled in Studies of BXQ-350PHASE1 · TERMINATED · started Jun 8, 2020ClinicalTrials.gov NCT04404569 · fetched Nov 12, 2026
- A Study of BXQ-350 in Children and Young Adults With Relapsed Solid TumorsPHASE1 · TERMINATED · started Apr 15, 2019ClinicalTrials.gov NCT03967093 · fetched Nov 12, 2026
- Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02859857 · fetched Nov 12, 2026